Current Oncology | Top 10 Most Cited Papers in 2021

As Current Oncology (ISSN: 1718-7729) has an open access format, you have free and unlimited access to the full text of all articles published in our journal. We welcome you to read our 2021 top cited papers listed below:

1. “Synovial Sarcoma: A Clinical Review”
by Aaron M. Gazendam, Snezana Popovic, Sohaib Munir, Naveen Parasu, David Wilson and Michelle Ghert
Curr. Oncol. 2021, 28(3), 1909–1920; https://doi.org/10.3390/curroncol28030177
Available online: https://www.mdpi.com/1718-7729/28/3/177

2. “The Out-of-Pocket Cost Burden of Cancer Care—A Systematic Literature Review”
by Nicolas Iragorri, Claire de Oliveira, Natalie Fitzgerald and Beverley Essue
Curr. Oncol. 2021, 28(2), 1216–1248; https://doi.org/10.3390/curroncol28020117
Available online: https://www.mdpi.com/1718-7729/28/2/117

3. “Current Overview of Treatment for Metastatic Bone Disease”
by Shinji Tsukamoto, Akira Kido, Yasuhito Tanaka, Giancarlo Facchini, Giuliano Peta, Giuseppe Rossi and Andreas F. Mavrogenis
Curr. Oncol. 2021, 28(5), 3347–3372; https://doi.org/10.3390/curroncol28050290
Available online: https://www.mdpi.com/1718-7729/28/5/290

4. “Pathological Features and Prognostication in Colorectal Cancer”
by Kabytto Chen, Geoffrey Collins, Henry Wang and James Wei Tatt Toh
Curr. Oncol. 2021, 28(6), 5356–5383; https://doi.org/10.3390/curroncol28060447
Available online: https://www.mdpi.com/1718-7729/28/6/447

5. “Extramammary Paget’s Disease: Diagnosis, Pathogenesis, and Treatment with Focus on Recent Developments”
by Shoichiro Ishizuki and Yoshiyuki Nakamura
Curr. Oncol. 2021, 28(4), 2969–2986; https://doi.org/10.3390/curroncol28040260
Available online: https://www.mdpi.com/1718-7729/28/4/260

6. “The Feasibility and Effects of a Telehealth-Delivered Home-Based Prehabilitation Program for Cancer Patients during the Pandemic”
by Fiona Wu, Oloruntobi Rotimi, Roberto Laza-Cagigas and Tarannum Rampal
Curr. Oncol. 2021, 28(3), 2248–2259; https://doi.org/10.3390/curroncol28030207
Available online: https://www.mdpi.com/1718-7729/28/3/207

7. “Canadian Consensus for Biomarker Testing and Treatment of TRK Fusion Cancer in Adults †”
by D. Gwyn Bebb, Shantanu Banerji, Normand Blais, Patrice Desmeules, Sharlene Gill, Andrea Grin, Harriet Feilotter, Aaron R. Hansen, Martin Hyrcza, Monika Krzyzanowska et al.
Curr. Oncol. 2021, 28(1), 523–548; https://doi.org/10.3390/curroncol28010053
Available online: https://www.mdpi.com/1718-7729/28/1/53

8. “Pretreatment Neutrophil-to-Lymphocyte Ratio as a Predictive Marker of Response to Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma”
by Yuji Eso, Haruhiko Takeda, Kojiro Taura, Atsushi Takai, Ken Takahashi and Hiroshi Seno
Curr. Oncol. 2021, 28(5), 4157–4166; https://doi.org/10.3390/curroncol28050352
Available online: https://www.mdpi.com/1718-7729/28/5/352

9. “Recent Radiomics Advancements in Breast Cancer: Lessons and Pitfalls for the Next Future”
by Filippo Pesapane, Anna Rotili, Giorgio Maria Agazzi, Francesca Botta, Sara Raimondi, Silvia Penco, Valeria Dominelli, Marta Cremonesi, Barbara Alicja Jereczek-Fossa, Gianpaolo Carrafiello et al.
Curr. Oncol. 2021, 28(4), 2351–2372; https://doi.org/10.3390/curroncol28040217
Available online: https://www.mdpi.com/1718-7729/28/4/217

10. “Belantamab Mafodotin to Treat Multiple Myeloma: A Comprehensive Review of Disease, Drug Efficacy and Side Effects”
by Grace Lassiter, Cole Bergeron, Ryan Guedry, Julia Cucarola, Adam M. Kaye, Elyse M. Cornett, Alan D. Kaye, Giustino Varrassi, Omar Viswanath and Ivan Urits
Curr. Oncol. 2021, 28(1), 640–660; https://doi.org/10.3390/curroncol28010063
Available online: https://www.mdpi.com/1718-7729/28/1/63